<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00671385</url>
  </required_header>
  <id_info>
    <org_study_id>BCA-003</org_study_id>
    <secondary_id>CA126441</secondary_id>
    <secondary_id>CA083597</secondary_id>
    <nct_id>NCT00671385</nct_id>
  </id_info>
  <brief_title>Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning</brief_title>
  <official_title>Early Screening of Breast Cancer Using Radiation-Free Pressure-Free Optical Scanning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectros Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Palo Alto Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Spectros Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study is to establish normal optical values of breast tissue in the
      general population. This will allow for establishing normals for breast composition, and is
      expected to be useful in the classification of breast lesions into groups such as cysts,
      benign growths, inflammatory lesions, and possibly early breast cancer.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2008</start_date>
  <completion_date type="Anticipated">April 2011</completion_date>
  <primary_completion_date type="Anticipated">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optical normals for the breast for a variety of conditions</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic compositional standards for (a) diagnosis of a condition such as cyst, benign growth, inflammation, and/or (b) referral for additional evaluation of a region of interest.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Breast Lesions</condition>
  <condition>Breast Cyst</condition>
  <condition>Early-Stage Breast Cancer</condition>
  <condition>Benign Growth, Breast</condition>
  <arm_group>
    <arm_group_label>Women 21-50 years old</arm_group_label>
    <description>Women without a diagnosis of cancer or a history of cancer.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women 18-50 with who EITHER (a) have a region of interest but without a diagnosis, or (b)
        are healthy volunteers without breast cancer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  You must be female

               -  You must be 21 to 50 years old

               -  You must not have or have had breast cancer.

               -  You must not have or have had breast implants or breast surgery

               -  You must not have had a breast biopsy or injury, or a breast infection, in 90
                  days.

        Exclusion Criteria:

          -  Any one or more of the above conditions not met

          -  Lack of informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A Benaron, MD</last_name>
    <role>Study Director</role>
    <affiliation>Spectros Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lizzy van Thillo, AA</last_name>
    <phone>650-851-4040</phone>
    <phone_ext>549</phone_ext>
    <email>lizzy@spectros.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carrie Bomarito, RN</last_name>
    <phone>650-851-4040</phone>
    <phone_ext>0</phone_ext>
    <email>info@spectros.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Spectros Corporation</name>
      <address>
        <city>Portola Valley</city>
        <state>California</state>
        <zip>94029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lizzy van Thillo, AA</last_name>
      <phone>650-851-4040</phone>
      <phone_ext>549</phone_ext>
      <email>lizzy@spectros.com</email>
    </contact>
    <contact_backup>
      <last_name>Carrie Bomarito, RN</last_name>
      <phone>640-851-4040</phone>
      <phone_ext>0</phone_ext>
      <email>info@spectros.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2008</study_first_submitted>
  <study_first_submitted_qc>May 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2008</study_first_posted>
  <last_update_submitted>January 30, 2011</last_update_submitted>
  <last_update_submitted_qc>January 30, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2011</last_update_posted>
  <responsible_party>
    <name_title>Clinical Studies Manager</name_title>
    <organization>Spectros Corporation</organization>
  </responsible_party>
  <keyword>screening</keyword>
  <keyword>compositional analysis</keyword>
  <keyword>metabolism</keyword>
  <keyword>breast</keyword>
  <keyword>breast cyst</keyword>
  <keyword>breast infection</keyword>
  <keyword>breast inflammation</keyword>
  <keyword>lipoma</keyword>
  <keyword>benign growth</keyword>
  <keyword>Women without a diagnosis for a region of interest in the breast</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Breast Cyst</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>May 23, 2016</submitted>
    <returned>June 30, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

